FDA
approval
· 2021-09-20
FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
Summary
The FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) from Allergan, updating the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)